BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

271 related articles for article (PubMed ID: 36838790)

  • 1. Critical Review on the Different Roles of Exosomes in TNBC and Exosomal-Mediated Delivery of microRNA/siRNA/lncRNA and Drug Targeting Signalling Pathways in Triple-Negative Breast Cancer.
    Banerjee M; Rajeswari VD
    Molecules; 2023 Feb; 28(4):. PubMed ID: 36838790
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Docetaxel-resistant triple-negative breast cancer cell-derived exosomal lncRNA LINC00667 reduces the chemosensitivity of breast cancer cells to docetaxel via targeting miR-200b-3p/Bcl-2 axis.
    Li J; Kang J; Liu W; Liu J; Pan G; Mao A; Zhang Q; Lu J; Ding J; Li H
    Eur J Histochem; 2022 Oct; 66(4):. PubMed ID: 36281649
    [TBL] [Abstract][Full Text] [Related]  

  • 3. LncRNA HAND2-AS1 suppressed the growth of triple negative breast cancer via reducing secretion of MSCs derived exosomal miR-106a-5p.
    Xing L; Tang X; Wu K; Huang X; Yi Y; Huan J
    Aging (Albany NY); 2020 Dec; 13(1):424-436. PubMed ID: 33290256
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Exosomes deliver lncRNA DARS-AS1 siRNA to inhibit chronic unpredictable mild stress-induced TNBC metastasis.
    Liu X; Zhang G; Yu T; He J; Liu J; Chai X; Zhao G; Yin D; Zhang C
    Cancer Lett; 2022 Sep; 543():215781. PubMed ID: 35688263
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Exosomes in triple negative breast cancer: Garbage disposals or Trojan horses?
    Goh CY; Wyse C; Ho M; O'Beirne E; Howard J; Lindsay S; Kelly P; Higgins M; McCann A
    Cancer Lett; 2020 Mar; 473():90-97. PubMed ID: 31904485
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Upregulation of serum exosomal SUMO1P3 predicts unfavorable prognosis in triple negative breast cancer.
    Na-Er A; Xu YY; Liu YH; Gan YJ
    Eur Rev Med Pharmacol Sci; 2021 Jan; 25(1):154-160. PubMed ID: 33506903
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Exosomal annexin A6 induces gemcitabine resistance by inhibiting ubiquitination and degradation of EGFR in triple-negative breast cancer.
    Li T; Tao Z; Zhu Y; Liu X; Wang L; Du Y; Cao J; Wang B; Zhang J; Hu X
    Cell Death Dis; 2021 Jul; 12(7):684. PubMed ID: 34238922
    [TBL] [Abstract][Full Text] [Related]  

  • 8. LncRNA AWPPH and miRNA-21 regulates cancer cell proliferation and chemosensitivity in triple-negative breast cancer by interacting with each other.
    Liu AN; Qu HJ; Gong WJ; Xiang JY; Yang MM; Zhang W
    J Cell Biochem; 2019 Sep; 120(9):14860-14866. PubMed ID: 31033015
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Exosomal MMP-1 transfers metastasis potential in triple-negative breast cancer through PAR1-mediated EMT.
    Zhu Y; Tao Z; Chen Y; Lin S; Zhu M; Ji W; Liu X; Li T; Hu X
    Breast Cancer Res Treat; 2022 May; 193(1):65-81. PubMed ID: 35254603
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long non-coding RNAs: implications in targeted diagnoses, prognosis, and improved therapeutic strategies in human non- and triple-negative breast cancer.
    Rodríguez Bautista R; Ortega Gómez A; Hidalgo Miranda A; Zentella Dehesa A; Villarreal-Garza C; Ávila-Moreno F; Arrieta O
    Clin Epigenetics; 2018; 10():88. PubMed ID: 29983835
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Engineering macrophage-derived exosomes for targeted chemotherapy of triple-negative breast cancer.
    Li S; Wu Y; Ding F; Yang J; Li J; Gao X; Zhang C; Feng J
    Nanoscale; 2020 May; 12(19):10854-10862. PubMed ID: 32396590
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Proliferation-associated long noncoding RNA, TMPO-AS1, is a potential therapeutic target for triple-negative breast cancer.
    Mitobe Y; Ikeda K; Sato W; Kodama Y; Naito M; Gotoh N; Miyata K; Kataoka K; Sasaki H; Horie-Inoue K; Inoue S
    Cancer Sci; 2020 Jul; 111(7):2440-2450. PubMed ID: 32437068
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The stromal loss of miR-4516 promotes the FOSL1-dependent proliferation and malignancy of triple negative breast cancer.
    Kim JE; Kim BG; Jang Y; Kang S; Lee JH; Cho NH
    Cancer Lett; 2020 Jan; 469():256-265. PubMed ID: 31672492
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Exosomes in triple negative breast cancer: From bench to bedside.
    Tang W; Xia M; Liao Y; Fang Y; Wen G; Zhong J
    Cancer Lett; 2022 Feb; 527():1-9. PubMed ID: 34902521
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Specific microRNA signatures in exosomes of triple-negative and HER2-positive breast cancer patients undergoing neoadjuvant therapy within the GeparSixto trial.
    Stevic I; Müller V; Weber K; Fasching PA; Karn T; Marmé F; Schem C; Stickeler E; Denkert C; van Mackelenbergh M; Salat C; Schneeweiss A; Pantel K; Loibl S; Untch M; Schwarzenbach H
    BMC Med; 2018 Oct; 16(1):179. PubMed ID: 30301470
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluating the influence of Human Umbilical Cord Mesenchymal Stem Cells-derived exosomes loaded with miR-3182 on metastatic performance of Triple Negative Breast Cancer cells.
    Khazaei-Poul Y; Shojaei S; Koochaki A; Ghanbarian H; Mohammadi-Yeganeh S
    Life Sci; 2021 Dec; 286():120015. PubMed ID: 34614416
    [TBL] [Abstract][Full Text] [Related]  

  • 17. LncRNA T376626 is a promising serum biomarker and promotes proliferation, migration, and invasion via binding to LAMC2 in triple-negative breast cancer.
    He Y; Xiao B; Lei T; Xuan J; Zhu Y; Kuang Z; Liu J; He J; Li L; Sun Z
    Gene; 2023 Apr; 860():147227. PubMed ID: 36709879
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Proteomic Landscape of Exosomes Reveals the Functional Contributions of CD151 in Triple-Negative Breast Cancer.
    Li S; Li X; Yang S; Pi H; Li Z; Yao P; Zhang Q; Wang Q; Shen P; Li X; Ji J
    Mol Cell Proteomics; 2021; 20():100121. PubMed ID: 34265469
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Systemic Delivery of Tumor-Targeting siRNA Nanoparticles against an Oncogenic LncRNA Facilitates Effective Triple-Negative Breast Cancer Therapy.
    Vaidya AM; Sun Z; Ayat N; Schilb A; Liu X; Jiang H; Sun D; Scheidt J; Qian V; He S; Gilmore H; Schiemann WP; Lu ZR
    Bioconjug Chem; 2019 Mar; 30(3):907-919. PubMed ID: 30739442
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Functional exosome-mediated co-delivery of doxorubicin and hydrophobically modified microRNA 159 for triple-negative breast cancer therapy.
    Gong C; Tian J; Wang Z; Gao Y; Wu X; Ding X; Qiang L; Li G; Han Z; Yuan Y; Gao S
    J Nanobiotechnology; 2019 Sep; 17(1):93. PubMed ID: 31481080
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.